Nathan Weinstein

Stock Analyst at Aegis Capital

(0)
# 4861
Out of 5,243 analysts
81
Total ratings
15.25%
Success rate
-27.70%
Average return
38 Stocks
Name Action Price Target Current % Upside Ratings Updated
Evogene
Maintains: Buy
100 80
1.57 4995.54% 2 Sep 12, 2022
DarioHealth
Maintains: Buy
20 15
0.74 1927.03% 6 Aug 18, 2022
VolitionRX
Maintains: Buy
9 6
0.63 852.38% 5 Aug 15, 2022
Immunic
Maintains: Buy
40 35
1 3400% 2 Aug 8, 2022
Stereotaxis
Initiates Coverage On: Buy
6
2.11 184.36% 1 Jul 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
1000
n/a n/a 1 Jun 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 30
2.35 1176.6% 4 May 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
3.83 161.1% 1 Mar 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
n/a n/a 1 Mar 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
63 49
19.54 150.77% 4 Mar 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
350 10
0.35 2757.14% 2 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
70
n/a n/a 2 Jan 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2160
4.8 44900% 1 Jan 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
1.9 1478.95% 1 Dec 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
750 600
0.58 103348.28% 2 Nov 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 10
1.11 800.9% 2 Nov 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12250 8750
n/a n/a 3 Sep 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
180 160
20.76 670.71% 2 Sep 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 56
28.33 97.67% 2 Sep 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 3
n/a n/a 4 Aug 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
26 27
1.43 1788.11% 3 Aug 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
n/a n/a 1 Jul 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
16 10
n/a n/a 3 Jun 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 35
1.17 2891.45% 4 Jun 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
2.31 419.48% 1 Mar 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
180
0.41 43802.44% 1 Mar 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 Feb 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
12.05 522.41% 1 Jan 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 11
0.34 3135.29% 3 Oct 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
180
2.9 6106.9% 1 Oct 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 9
0.12 6775% 2 Sep 29, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
104 12
n/a n/a 2 Sep 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 47
n/a n/a 2 Aug 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 9
0.67 1243.28% 3 Aug 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
5.03 178.33% 1 Jul 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 11
0.54 1937.04% 2 May 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 0
n/a n/a 1 Mar 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
2.38 257.14% 1 Mar 23, 2020